🇺🇸 FDA
Pipeline program

TAEST16001

2017-ZLZX-001

Phase 1 small_molecule completed

Quick answer

TAEST16001 for Liver Cancer Stage IV is a Phase 1 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Liver Cancer Stage IV
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials